Moneycontrol
HomeNewscoronavirusIndia reports 3,805 fresh COVID-19 cases, 22 fatalities in last 24 hours

India reports 3,805 fresh COVID-19 cases, 22 fatalities in last 24 hours

The daily positivity rate was recorded at 0.78 per cent and the weekly positivity rate at 0.79 per cent, the ministry said.

May 07, 2022 / 10:41 IST
Story continues below Advertisement
A patient suffering from COVID-19 (Image: Reuters)

India reported 3,805 new coronavirus infections in a day, pushing the number of active cases of the disease in the country to 20,303 and the overall tally to 4,30,98,743, according to Union Health Ministry data updated on Saturday. The data released at 8 am also showed that 22 fatalities — 20 of them from Kerala alone — were reported in a 24-hour period, taking the cumulative death toll to 5,24,024.

The active cases now constitute 0.05 per cent of the total infections, the health ministry said, adding that the country's COVID-19 recovery rate is at 98.74 per cent. The daily positivity rate was recorded at 0.78 per cent and the weekly positivity rate at 0.79 per cent, the ministry said.

Story continues below Advertisement

A total of 84.03 crore Covid tests have been conducted so far, including 4,87,544 a day ago. An increase of 615 cases has been recorded in the active COVID-19 caseload, which now stands at 20,303.

The number of people who have recuperated from the disease rose to 4,25,54,416, while the case fatality rate was recorded at 1.22 per cent, the data showed. The cumulative number doses administered in the country so far under the nationwide COVID-19 vaccination drive has exceeded 190 crore.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show